Meningitis/Encephalitis
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001
MUSic Therapy In Complex Specialist Neurorehabilitation
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study
Brazil ICU Encephalitis Surveillance
A Diagnostic Test on DeepDoc-an AI-based Decision Support System
Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel